ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 78 filers reported holding ITEOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,054,602 | -11.9% | 278,959 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $3,467,145 | -2.8% | 261,869 | -0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,565,207 | -33.5% | 261,955 | -4.5% | 0.00% | 0.0% |
| Q4 2022 | $5,358,505 | +31.2% | 274,373 | +28.0% | 0.00% | 0.0% |
| Q3 2022 | $4,083,000 | +9.8% | 214,291 | +18.7% | 0.00% | 0.0% |
| Q2 2022 | $3,718,000 | -38.1% | 180,511 | -3.4% | 0.00% | 0.0% |
| Q1 2022 | $6,011,000 | +25.8% | 186,800 | +82.0% | 0.00% | 0.0% |
| Q4 2021 | $4,777,000 | +147.6% | 102,614 | +43.6% | 0.00% | – |
| Q3 2021 | $1,929,000 | +29.4% | 71,460 | +22.9% | 0.00% | – |
| Q2 2021 | $1,491,000 | -20.9% | 58,130 | +5.5% | 0.00% | – |
| Q1 2021 | $1,884,000 | +35.0% | 55,111 | +33.6% | 0.00% | – |
| Q4 2020 | $1,396,000 | +94.4% | 41,260 | +41.9% | 0.00% | – |
| Q3 2020 | $718,000 | – | 29,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |